المؤلفون: Diederik M. Somford, Reindert J.A. van Moorselaar, Carin A. Uyl-de Groot, Ronald de Wit, Laurent M.C.L. Fossion, Niven Mehra, Hans M. Westgeest, Addy C. M. van de Luijtgaarden, Juleon L.L.M. Coenen, N.I. Weijl, Maud M. Geenen, Winald R. Gerritsen, Agnes J. van de Wouw, A.C.M. van den Bergh, Mathijs P. Hendriks, Marco B. Polee, Alphonsus J. M. van den Eertwegh, Andre M. Bergman, Malou C.P. Kuppen, Inge M. van Oort, Daan ten Bokkel Huinink

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical oncology, Urology, CCA - Cancer Treatment and quality of life, Internal medicine

المصدر: European urology oncology, 4(4), 618-627. De Tijdstroom/Elsevier
European Urology Oncology, 4, 618-627
European urology oncology, 4, 618-627. Elsevier
Kuppen, M C P, Westgeest, H M, van den Eertwegh, A J M, van Moorselaar, R J A, van Oort, I M, Coenen, J L L M, van den Bergh, A C M F, Mehra, N, Somford, D M, Bergman, A M, Ten Bokkel Huinink, D, Fossion, L, Geenen, M M, Hendriks, M P, van de Luijtgaarden, A C M, Polee, M B, Weijl, N I, van de Wouw, A J, de Wit, R, Uyl-de Groot, C A & Gerritsen, W R 2021, ' Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer : Results from the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Oncology, vol. 4, no. 4, pp. 618-627 . https://doi.org/10.1016/j.euo.2019.09.005Test
European Urology Oncology, 4, 4, pp. 618-627
European Urology Oncology, 4(4), 618-627. Elsevier BV

مصطلحات موضوعية: Oncology, Male, ANTITUMOR-ACTIVITY, 030232 urology & nephrology, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Prednisone, Medicine, Sequencing, Registries, Castration-resistant prostate cancer, DOCETAXEL, Abiraterone acetate, TIME, Prostatic Neoplasms, Castration-Resistant, TRIALS, Docetaxel, Pharmaceutical Preparations, Cabazitaxel, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Androgens, Cross resistance, medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, ENZALUTAMIDE, Urology, INCREASED SURVIVAL, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Antigen, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Enzalutamide, Humans, Radiology, Nuclear Medicine and imaging, Real-world outcomes, Retrospective Studies, Androgen-receptor targeting agents, business.industry, Androgen Antagonists, medicine.disease, Androgen receptor, chemistry, Surgery, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5688ade1d20f2f2f131d73a057ff810Test
https://research.rug.nl/en/publications/41b16b5e-d8f6-46e7-904f-77d48f068028Test

المؤلفون: Alphons C.M. van den Bergh, Hans M. Westgeest, Walter L. Vervenne, Niven Mehra, Diederik M. Somford, Jules L.L.M. Coenen, Inge M. van Oort, Alfons J.M. van den Eertwegh, Malou C.P. Kuppen, Reindert J.A. van Moorselaar, Jessica Notohardjo, Carin A. Uyl-de Groot, Winald R. Gerritsen, Aad I. de Vos, Katja K.H. Aben, Andries M. Bergman

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical oncology, Urology, CCA - Cancer Treatment and quality of life

المصدر: European Urology Focus, 7, 4, pp. 788-796
European Urology Focus, 7(4), 788-796. De Tijdstroom/Elsevier
Notohardjo, J C L, Kuppen, M C P, Westgeest, H M, van Moorselaar, R J A, Mehra, N, Coenen, J L L M, van Oort, I M, de Vos, A I, Vervenne, W L, van den Bergh, A C M, Aben, K K H, Somford, D M, Bergman, A M, Uyl-de Groot, C A, Gerritsen, W R & van den Eertwegh, A J M 2021, ' Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population : Results from the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Focus, vol. 7, no. 4, pp. 788-796 . https://doi.org/10.1016/j.euf.2020.03.009Test
European Urology Focus. Elsevier
European Urology Focus, 7, 788-796
European Urology Focus, 7(4), 788-796. Elsevier BV

مصطلحات موضوعية: Male, Oncology, PREDNISONE, medicine.medical_specialty, ENZALUTAMIDE, Urology, ANTITUMOR-ACTIVITY, Population, 030232 urology & nephrology, Life-prolonging drug, Castration resistant, 03 medical and health sciences, Drug treatment, Prostate cancer, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, hemic and lymphatic diseases, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Humans, Real-world outcomes, Prospective Studies, Registries, education, Retrospective Studies, Castration-resistant prostate cancer, DOCETAXEL, education.field_of_study, business.industry, Real world outcomes, Third line, CHEMOTHERAPY, Prognosis, medicine.disease, PROGNOSTIC MODEL, MITOXANTRONE, Clinical Practice, ABIRATERONE ACETATE, Prostatic Neoplasms, Castration-Resistant, 030220 oncology & carcinogenesis, CABAZITAXEL, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Prognostic model, SURVIVAL, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863af5bcaa0e4492253e7fa5bfd10a57Test
https://repository.ubn.ru.nl/handle/2066/237201Test

المؤلفون: Paul J.M. Kil, Carin A. Uyl-de Groot, Johanna J.M. Takkenberg, Hans M. Westgeest, Kevin M Veen, M. Mostafa Mokhles, Isabel B. de Angst, Winald R. Gerritsen, Malou C.P. Kuppen

المساهمون: Cardiothoracic Surgery, Health Technology Assessment (HTA)

المصدر: Journal of Cancer Research and Clinical Oncology, 146, 2067-2075. Springer-Verlag
Journal of Cancer Research and Clinical Oncology, 146, 2067-2075
Journal of Cancer Research and Clinical Oncology, 146, 8, pp. 2067-2075
Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Male, Cancer Research, Review – Clinical Oncology, Computer science, Clinical Decision-Making, Machine learning, computer.software_genre, 01 natural sciences, 010104 statistics & probability, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Lasso (statistics), SDG 3 - Good Health and Well-being, medicine, Humans, 030212 general & internal medicine, Registries, 0101 mathematics, Castration-resistant prostate cancer, Netherlands, Proportional Hazards Models, Retrospective Studies, Models, Statistical, Proportional hazards model, business.industry, General Medicine, Missing data, medicine.disease, Decision Support Systems, Clinical, Regression, Prostatic Neoplasms, Castration-Resistant, Specification, Oncology, Prediction modeling, Cox proportional hazard model, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Regression Analysis, Artificial intelligence, business, computer, Statistician, Coding (social sciences), Decision-making

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3417c1289a73f67b18a369cc28e6a76eTest
https://pure.eur.nl/en/publications/d9c008f1-f498-4ef5-94d3-42786d5f1a55Test